An evaluation of COVID-19 serological assays informs future diagnostics and exposure assessment

An evaluation of COVID-19 serological assays informs future diagnostics and exposure assessment

SARS-CoV-2 is causing a global pandemic in which the implementation of serology can support decision making in different scenarios. Here, the authors compare the outcome of eight commercially available assays to virus neutralization and discuss their use in diagnostics and exposure assessment of SAR...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Corine H. GeurtsvanKessel, Nisreen M. A. Okba, Zsofia Igloi, Susanne Bogers, Carmen W. E. Embregts, Brigitta M. Laksono, Lonneke Leijten, Casper Rokx, Bart Rijnders, Janette Rahamat-Langendoen, Johannes P. C. van den Akker, Jeroen J. A. van Kampen, Annemiek A. van der Eijk, Rob S. van Binnendijk, Bart Haagmans, Marion Koopmans
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2020
Materias:
Science
Q
Acceso en línea:https://doaj.org/article/2ac309c3223340199fb8d84c073240df
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
Descripción
Sumario:SARS-CoV-2 is causing a global pandemic in which the implementation of serology can support decision making in different scenarios. Here, the authors compare the outcome of eight commercially available assays to virus neutralization and discuss their use in diagnostics and exposure assessment of SARS-CoV-2.

Ejemplares similares